12/19/2023 0 Comments Bio rad laboratories![]() Hedge funds and other institutional investors own 63.66% of the company’s stock. Worldquant Millennium Advisors LLC now owns 9,012 shares of the medical research company’s stock valued at $5,076,000 after acquiring an additional 1,512 shares in the last quarter. Finally, Worldquant Millennium Advisors LLC increased its stake in shares of Bio-Rad Laboratories by 20.2% in the 1st quarter. Gabelli Funds LLC now owns 28,800 shares of the medical research company’s stock valued at $16,221,000 after acquiring an additional 295 shares in the last quarter. Gabelli Funds LLC increased its stake in shares of Bio-Rad Laboratories by 1.0% in the 1st quarter. ![]() BNP Paribas Arbitrage SA now owns 15,856 shares of the medical research company’s stock valued at $8,931,000 after acquiring an additional 7,935 shares in the last quarter. BNP Paribas Arbitrage SA increased its stake in shares of Bio-Rad Laboratories by 100.2% in the 1st quarter. EP Wealth Advisors LLC bought a new stake in shares of Bio-Rad Laboratories in the 1st quarter valued at $218,000. ![]() Walleye Capital LLC now owns 8,644 shares of the medical research company’s stock worth $4,869,000 after purchasing an additional 7,600 shares during the last quarter. Walleye Capital LLC raised its holdings in Bio-Rad Laboratories by 728.0% during the 1st quarter. Currently, 1.9% of the shares of the stock are short sold.Ī number of institutional investors have recently added to or reduced their stakes in the business. Based on an average daily volume of 231,900 shares, the short-interest ratio is presently 1.8 days. As of May 15th, there was short interest totalling 408,000 shares, an increase of 22.6% from the April 30th total of 332,800 shares. ( NYSE:BIO – Get Rating) saw a large increase in short interest in May.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |